Cargando…

Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis

The objective of this retrospective cohort study was to determine the effect of tumor necrosis factor inhibitor (TNFi) therapy on the risk of head and neck cancer (HNC) recurrence or HNC-attributable death in patients with rheumatoid arthritis (RA). RA patients with HNC were assembled from the US na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, Christopher, Zeringue, Angelique L., McDonald, Jay R., Eisen, Seth A., Ranganathan, Prabha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658068/ https://www.ncbi.nlm.nih.gov/pubmed/26599370 http://dx.doi.org/10.1371/journal.pone.0143286

Ejemplares similares

Head and neck reconstruction
por: Yadav, Prabha
Publicado: (2013)

Symptomatic femoral head necrosis in patients with rheumatoid arthritis: A retrospective case‐control study
por: Wei, Qijiao, et al.
Publicado: (2022)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Recent advances in head and neck cancer reconstruction
por: Yadav, Prabha
Publicado: (2014)

Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor
por: Aberumand, Babak, et al.
Publicado: (2014)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
por: Leandro, Maria J
Publicado: (2009)

Sudden cardiac death in patients with rheumatoid arthritis
por: Masoud, Sherry, et al.
Publicado: (2017)

Postoperative avascular necrosis of the femoral head in pediatric femoral neck fractures
por: Li, Yang, et al.
Publicado: (2022)

How real-world evidence can really deliver: a case study of data source development and use
por: Drozda, Joseph, et al.
Publicado: (2020)

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
por: Shin, Sungsik, et al.
Publicado: (2016)

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis
por: Martínez-Santana, Virginia, et al.
Publicado: (2013)

Life-Threatening Gastrointestinal Mucosal Necrosis during Methotrexate Treatment for Rheumatoid Arthritis
por: Tsukada, Tomoya, et al.
Publicado: (2013)

Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis
por: Perpétuo, Inês P., et al.
Publicado: (2017)

Tumor necrosis factor α-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis
por: Inoue, Asuka, et al.
Publicado: (2009)

Postsurgical pyoderma gangrenosum and flap necrosis in a head and neck cancer patient following neck dissection
por: Arebro, Julia, et al.
Publicado: (2020)

Treatment Comparison in Rheumatoid Arthritis: Head-to-Head Trials and Innovative Study Designs
por: Favalli, Ennio Giulio, et al.
Publicado: (2014)

Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate
por: O’Dell, James R, et al.
Publicado: (2018)

Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis
por: Bonetti, N. R., et al.
Publicado: (2019)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Risk Factors for Avascular Necrosis of the Femoral Head in Pediatric Femoral Neck Fractures
por: Chaudhary, Sunny, et al.
Publicado: (2021)

Effect of vitamin D on the recurrence rate of rheumatoid arthritis
por: YANG, JUNXIA, et al.
Publicado: (2015)

Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base
por: Kitpanit, Sarin, et al.
Publicado: (2020)

Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
por: Ernestam, Sofia, et al.
Publicado: (2006)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka, Toshio, et al.
Publicado: (2014)

Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis
por: Reams, Jennifer, et al.
Publicado: (2020)

Characterization and Function of Tumor Necrosis Factor and Interleukin‐6–Induced Osteoclasts in Rheumatoid Arthritis
por: Yokota, Kazuhiro, et al.
Publicado: (2021)

Predictors of Treatment Initiation with Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis
por: Desai, Rishi J., et al.
Publicado: (2014)

TERT Promoter Mutation C228T Increases Risk for Tumor Recurrence and Death in Head and Neck Cancer Patients
por: Arantes, Lidia Maria Rebolho Batista, et al.
Publicado: (2020)

Cell death in head and neck cancer pathogenesis and treatment
por: Raudenská, Martina, et al.
Publicado: (2021)

Association between Weitbrecht's Retinaculum Injury and Femoral Head Necrosis in Femoral Neck Fractures
por: Mei, Jiong, et al.
Publicado: (2022)

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
por: Ogdie, Alexis, et al.
Publicado: (2022)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
por: Alonso-Ruiz, Alberto, et al.
Publicado: (2008)

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy
por: Leboime, Ariane, et al.
Publicado: (2009)

Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
por: Kang, Ji-Hyoun, et al.
Publicado: (2014)

Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis
por: Fisher, Anat, et al.
Publicado: (2016)

Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis
por: Low, Audrey S. L., et al.
Publicado: (2016)

Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?
por: Huang, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_virkqslh7em8cbhgvopkh1ofjm